Factors Influencing Behavioral Intention Regarding Prostate Cancer Screening Among Older African-American Men

Overview

Journal J Natl Med Assoc

Publisher Elsevier

Specialty General Medicine

Date 2006 Apr 21

PMID 16623062

Citations 29

Authors

Marvella E Ford

Sally W Vernon

Suzanne L Havstad

Shirley A Thomas

Shawna D Davis

Affiliations

Soon will be listed here.

Abstract

Purpose: To assess factors associated with perceptions of prostate cancer screening among African-American men aged > or = 55 years based upon items developed using the Preventive Health model (PHM).

Research Approach: Focus group research and thematic coding using content analysis.

Setting: A large midwestern, private, nonprofit health system.

Participants: African-American men aged > or = 55 years. Focus group 1 included 10 men who ranged in age from 55-87 years, with a mean age of 73.4 years. The 11 participants in focus group 2 ranged in age from 55-81 years, with a mean age of 68.7 years.

Methodological Approach: Focus group questions were developed based on the conceptual framework of the PHM. African-American men aged > or = 55 years were randomly selected from the patient population of the healthcare system to participate in one of two focus groups. Content analysis was used to code the focus group transcripts.

Main Research Variables: Self-reported perceptions of prostate cancer screening.

Findings: Major themes emerging from the focus groups related to prostate cancer screening include: lack of knowledge regarding cancer, fear of cancer, confusion between prostate cancer screening and prostate cancer diagnostic tests, encouragement by others as motivation for cancer screening, intergenerational transfer of health information, lack of health insurance coverage as a barrier to prostate cancer screening and treatment, and limited availability of screening clinic hours during nonworking hours.

Interpretation: The information gained from this study could be used to develop interventions promoting informed and shared decision-making by patients and their providers regarding prostate cancer screening.

Citing Articles

Patient Communication Preferences for Prostate Cancer Screening Discussions: A Scoping Review.

Fong J, Venables M, DSouza D, Maskerine C Ann Fam Med. 2023; 21(5):448-455.

PMID: 37748915 PMC: 10519764. DOI: 10.1370/afm.3011.

Reactions to Recommendations and Evidence About Prostate Cancer Screening Among White and Black Male Veterans.

Danan E, White K, Wilt T, Partin M Am J Mens Health. 2021; 15(3):15579883211022110.

PMID: 34096377 PMC: 8188983. DOI: 10.1177/15579883211022110.

Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.

Zhang D, Advani S, Huchko M, Braithwaite D BMJ Open. 2020; 10(1):e031823.

PMID: 31911515 PMC: 6955489. DOI: 10.1136/bmjopen-2019-031823.

Factors Associated With Cancer Family History Communication Between African American Men and Their Relatives.

Mitchell J, Hawkins J, Watkins D J Mens Stud. 2019; 21(2):97-111.

PMID: 31289433 PMC: 6615889. DOI: 10.3149/jms.2102.97.

Choosing Channels, Sources, and Content for Communicating Prostate Cancer Information to Black Men: A Systematic Review of the Literature.

Walsh-Childers K, Odedina F, Poitier A, Kaninjing E, Taylor 3rd G Am J Mens Health. 2018; 12(5):1728-1745.

PMID: 30045654 PMC: 6142158. DOI: 10.1177/1557988318786669.

References

Stallings F, Ford M, Simpson N, Fouad M, Jernigan J, Trauth J . Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2001; 21(6 Suppl):379S-389S. DOI: 10.1016/s0197-2456(00)00093-3. View

Kohler C, DOLCE J, Manzella B, Higgins D, Brooks C, RICHARDS Jr J . Use of focus group methodology to develop an asthma self-management program useful for community-based medical practices. Health Educ Q. 1993; 20(3):421-9. DOI: 10.1177/109019819302000311. View

Myers R, Hyslop T, Wolf T, Burgh D, Kunkel E, Oyesanmi O . African-American men and intention to adhere to recommended follow-up for an abnormal prostate cancer early detection examination result. Urology. 2000; 55(5):716-20. DOI: 10.1016/s0090-4295(99)00588-9. View

Ghafoor A, Jemal A, Cokkinides V, Cardinez C, Murray T, Samuels A . Cancer statistics for African Americans. CA Cancer J Clin. 2002; 52(6):326-41. DOI: 10.3322/canjclin.52.6.326. View

Bulmer C . Clinical decisions: defining meaning through focus groups. Nurs Stand. 1998; 12(20):34-6. DOI: 10.7748/ns.12.20.34.s51. View

Sim J . Collecting and analysing qualitative data: issues raised by the focus group. J Adv Nurs. 1998; 28(2):345-52. DOI: 10.1046/j.1365-2648.1998.00692.x. View

Weinrich S, Greiner E, Yoon S, Weinrich M . Predictors of participation in prostate cancer screening at worksites. J Community Health Nurs. 1998; 15(2):113-29. DOI: 10.1207/s15327655jchn1502_5. View

Powell I, Schwartz K, Hussain M . Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. Urology. 1995; 46(6):825-30. DOI: 10.1016/S0090-4295(99)80352-5. View

Ford S, Schofield T, Hope T . What are the ingredients for a successful evidence-based patient choice consultation?: A qualitative study. Soc Sci Med. 2003; 56(3):589-602. DOI: 10.1016/s0277-9536(02)00056-4. View

10.

Woods V, Montgomery S, Belliard J, Ramirez-Johnson J, Wilson C . Culture, black men, and prostate cancer: what is reality?. Cancer Control. 2004; 11(6):388-96. PMC: 4654412. DOI: 10.1177/107327480401100606. View

11.

Stevenson F, Barry C, Britten N, Barber N, Bradley C . Doctor-patient communication about drugs: the evidence for shared decision making. Soc Sci Med. 2000; 50(6):829-40. DOI: 10.1016/s0277-9536(99)00376-7. View

12.

Ahaghotu C, Baffoe-Bonnie A, Kittles R, Pettaway C, Powell I, Royal C . Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC Study. Prostate Cancer Prostatic Dis. 2004; 7(2):165-9. DOI: 10.1038/sj.pcan.4500719. View

13.

Janz N, BECKER M . The Health Belief Model: a decade later. Health Educ Q. 1984; 11(1):1-47. DOI: 10.1177/109019818401100101. View

14.

Gulick E . Social support among persons with multiple sclerosis. Res Nurs Health. 1994; 17(3):195-206. DOI: 10.1002/nur.4770170307. View

15.

Gafni A, Charles C, Whelan T . The physician-patient encounter: the physician as a perfect agent for the patient versus the informed treatment decision-making model. Soc Sci Med. 1998; 47(3):347-54. DOI: 10.1016/s0277-9536(98)00091-4. View

16.

Weinrich S, Reynolds Jr W, Tingen M, Starr C . Barriers to prostate cancer screening. Cancer Nurs. 2000; 23(2):117-21. DOI: 10.1097/00002820-200004000-00007. View

17.

Gattellari M, Ward J . A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Patient Educ Couns. 2005; 57(2):168-82. DOI: 10.1016/j.pec.2004.05.011. View

18.

BECKER M, Radius S, Rosenstock I, DRACHMAN R, Schuberth K, Teets K . Compliance with a medical regimen for asthma: a test of the health belief model. Public Health Rep. 1978; 93(3):268-77. PMC: 1431906. View

19.

Ndubuisi S, Kofie V, Andoh J, SCHWARTZ E . Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology. 1995; 46(1):71-7. DOI: 10.1016/S0090-4295(99)80162-9. View

20.

Powell I, Banerjee M, Novallo M, Sakr W, Grignon D, Wood D . Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Urology. 2000; 55(2):246-51. DOI: 10.1016/s0090-4295(99)00436-7. View